Human Cytolytic Fusion Proteins: Modified Versions of Human Granzyme B and Angiogenin Have the Potential to Replace Bacterial Toxins in Targeted Therapies against CD64+ Diseases

Author: Berges Nina   Hehmann-Titt Grit   Hristodorov Dmitrij   Melmer Georg   Thepen Theo   Barth Stefan  

Publisher: MDPI

E-ISSN: 2073-4468|3|1|92-115

ISSN: 2073-4468

Source: Antibodies, Vol.3, Iss.1, 2014-02, pp. : 92-115

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content